Bridging the Divide: How Mindr Is Bringing Alzheimer’s Research to Life
Alzheimer’s disease has long been a formidable challenge, but recent scientific breakthroughs offer a glimmer of hope. The FINGER study, a landmark in Alzheimer’s research, demonstrated the power of simple lifestyle changes in preventing cognitive decline. However, translating these findings into practical, everyday strategies has proven elusive.
In this episode of StartUp Health NOW, we explore how Mindr, a pioneering startup in our Alzheimer’s Moonshot Community, is bridging the gap between research – the FINGER study – and real-world application in the lives of people at risk for Alzheimer’s and dementia. By leveraging the best of modern consumer tech – like a well designed app on your phone – Mindr aims to make internationally-recognized advances in healthcare accessible to everyone.
This is a story that applies in almost every area of health. We have the information, but we struggle to get it out of the lab, out of the peer reviewed journal, and into everyday life. Mindr’s co-founders Adam Schultz and Ariana Myers explain how they’re attempting to bridge this divide and what it will take to succeed on a bigger scale.
Join us as we discuss the importance of connecting research to practice and how Mindr is empowering individuals to take proactive steps toward a healthier brain.
Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot.
Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
